1Giannarini G, Zazzara M, Rossanese M, et al. Will muhi- parametric magnetic resonance imaging be the future tool to detect clinically significant prostate cancer.? [ J]. Front Oncol, 2014,4 (4) :294.
2Katelaris NC, Bohon DM, Weerakoon M, et al. Current role of multiparametric magnetic resonance imaging in the management of prostate cancer[ J 1. Korean J Urol,2015,56 (5) : 337-345.
3Beyersdorff D,Taupitz M, Winkehnann B, et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectM US-guided quadrant or sextant biopsy results: value of MR imaging [ J ]. Radiology, 2002,224 ( 3 ) : 701-706.
4Choi YJ, Kim JK, Kim N, et al. Functional MR imaging of prostate cancer [ J ]. Radiographies, 2007,27 ( 1 ) : 63-75.
5Akin 0, Hricak H. Imaging of prostate cancer[ J]. Radiol Clin North Am, 2007, 45 ( 1 ) : 207-222.
6Verma S, Turkbey B, Muradyan N, et al. Overview of Dynamic Contrast-Enhanced MRI in Prostate Cancer Diagnosis and Managrment[ J ]. AJR Am J Roentgenol, 2012, 198 ( 6 ) : 1277- 1288.
7Turkbey B, Choyke PL. Muhiparametric MRI and prostate cancer diagnosis and risk stratification [ J]. Curt Opin Urol,2012,22 (4) : 310-315.
8Hoeks CM, Barentsz JO, Hambrock T, et al. Prostate cancer: muhiparametric MR imaging for detection, localization, and staging[ J]. Radiology, 2011,261 ( 1 ) : 46-66.
9Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers : features, detection, localization, and staging at endorectal MR imaging [ J ]. Radiology, 2006,239 ( 3 ) : 784-792.
10Langer DL, van der Kwast TH, Evans A J, et al. Prostate cancer detection with multi-parametric MRI : logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI [ J ]. J Magn Reson Imaging, 2009,30 (2) :327-334.
